MRVI logo

MRVI Stock Overview

Profile

Full Name:

Maravai LifeSciences Holdings, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

November 20, 2020

Indexes:

Not included

Website:

http://www.maravai.com

Description:

Maravai LifeSciences Holdings is a biotechnology company that provides essential products and services for the development of vaccines and therapies. They specialize in nucleic acid production, offering tools for research and manufacturing to support the life sciences industry.

Key Details

Price

$3.15

Market Cap

$446.10 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$288.94 M(-67.28% YoY)

Annual EPS

-$0.90(-153.89% YoY)

PE Ratio

-

Annual ROE

-14.04%

Annual Debt To Equity

1.26

Beta

0.82

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Feb 25, 2025

Recent annual earnings:

Feb 25, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Dec 5, 24 Goldman Sachs
Sell
Nov 14, 24 Wolfe Research
Peer Perform
Nov 8, 24 William Blair
Market Perform
Nov 8, 24 RBC Capital
Outperform
Nov 8, 24 Baird
Outperform
Oct 8, 24 Goldman Sachs
Neutral
Aug 27, 24 Wells Fargo
Overweight
Aug 16, 24 RBC Capital
Outperform
Aug 13, 24 Morgan Stanley
Equal-Weight
Aug 8, 24 UBS
Neutral

Screeners with MRVI included

Growing Shares Outstanding
US stocks
Stocks below SMA 200
Most recommended stocks
Earnings this week
Stocks with low RSI
Stocks below analysts price target
Healthcare sector
All stocks
Biotechnology industry

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$3.15
MRVI price is $3.15

Price All-time High

$60.62
MRVI price is currently -94.81% below its historical high of $60.62

Price Analysts Target

$9.50
MRVI price is currently -66.89% lower than the consensus analysts' forecast

Price Today Change

+1.78%
MRVI price is up +1.78% today

Price YTD Change

-40.1%
MRVI price is down -40.1% since January 1st

Price 3-Year Change

-91.53%
MRVI price is down -91.53% over the past 3 years

Market cap

Market Cap

$446.10 M
MRVI market capitalization is $446.10 million

Market Cap 3-Year Change

-90.86%
MRVI market capitalization is down -90.86% over the past 3 years

Market Cap All-time High

$6.93 B
MRVI market capitalization is currently -93.56% below its historical high of $6.93 billion

Market Cap Sector Rank

66.42%
MRVI market capitalization is higher than 66.42% of companies in Healthcare sector

Technical

Beta

0.82
MRVI beta is 0.82

200-day SMA

$7.31
MRVI price is currently -56.97% below its 200-day simple moving average

14-day RSI

22.87
MRVI 14-day relative strength index is 22.87

30-day Relative Volume

1.45
MRVI 30-day relative volume is 1.45

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$288.94 M
MRVI annual revenue is $288.94 million

Annual Revenue Analysts Estimate

$260.53 M
MRVI annual revenue is currently +10.91% higher than the consensus analysts' forecast

Annual Revenue 1-Year Change

-67.28%
MRVI annual revenue is down -67.28% year-on-year

Annual Revenue Sector Rank

69.23%
MRVI annual revenue is higher than 69.23% of companies in Healthcare sector

Profit

Annual Gross Profit

$140.20 M
MRVI annual gross profit is $140.20 million

Annual Gross Margin

48.52%
MRVI annual gross profit margin is 48.52%

Annual Operating Profit

-$28.47 M
MRVI annual operating income is -$28.47 million

Annual Operating Margin

-9.85%
MRVI annual operating profit margin is -9.85%

Annual Net Income

-$119.03 M
MRVI annual net profit is -$119.03 million

Annual Net Margin

-41.19%
MRVI annual net profit margin is -41.19%

EPS

Annual EPS

-$0.90
MRVI annual earnings per share is -$0.90

Annual EPS Analysts Estimate

-$0.08
MRVI annual earnings per share is currently +1036.36% higher than the consensus analysts' forecast

Annual EPS 1-Year Change

-153.89%
MRVI annual earnings per share is down -153.89% year-on-year

Annual EPS Sector Rank

62.96%
MRVI annual earnings per share is higher than 62.96% of companies in Healthcare sector

ROA & ROE

Annual ROA

-6.31%
MRVI annual return on assets is -6.31%

Annual ROE

-14.04%
MRVI annual return on equity is -14.04%

EBIT & EBITDA

Annual EBIT

$663.63 M
MRVI annual earnings before interest & taxes is $663.63 million

Annual EBITDA

$663.63 M
MRVI annual EBITDA is $663.63 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
MRVI price to earnings ratio value is unknown

PE Ratio Sector Rank

-
MRVI price to earnings ratio is unknown

PB Ratio

PB Ratio

1.29
MRVI price to book ratio is 1.29

PB Ratio Sector Rank

48.52%
MRVI price to book ratio is higher than 48.52% of companies in Healthcare sector

PS Ratio

PS Ratio

1.61
MRVI price to sales ratio is 1.61

PS Ratio Sector Rank

34.79%
MRVI price to sales ratio is higher than 34.79% of companies in Healthcare sector

Enterprise value

Enterprise Value

$429.02 M
MRVI enterprise value is $429.02 million

Enterprise Value Sector Rank

66.89%
MRVI enterprise value is higher than 66.89% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.80
MRVI EV/EBITDA is 0.80

EV/EBITDA Sector Rank

75.77%
MRVI EV/EBITDA is higher than 75.77% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

8.00
MRVI annual current ratio is 8.00

Annual Quick Ratio

7.41
MRVI annual quick ratio is 7.41

Leverage

Annual Debt To Equity

1.26
MRVI annual debt to equity ratio is 1.26

Annual Interest Coverage Ratio

14.46
MRVI annual interest coverage ratio is 14.46

Risk & Stability

Piotroski F-Score

5
MRVI piotroski f-score is 5

Altman Z-Score

2.81
MRVI altman z-score is 2.81

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$1.49 B
MRVI annual total assets is $1.49 billion

Annual Non Current Assets

$787.54 M
MRVI annual long term assets is $787.54 million

Annual Current Assets

$699.91 M
MRVI annual total current assets is $699.91 million

Annual Cash & Cash Equivalents

$574.96 M
MRVI annual cash & cash equivalents is $574.96 million

Equity

Annual Book Value

$416.75 M
MRVI annual book value is $416.75 million

Annual Working Capital

$612.44 M
MRVI annual working capital is $612.44 million

Liabilities

Annual Total Liabilities

$697.57 M
MRVI annual total liabilities is $697.57 million

Annual Total Long Term Liabilities

$610.10 M
MRVI annual total long term liabilities is $610.10 million

Annual Current Liabilities

$87.47 M
MRVI annual total current liabilities is $87.47 million

Annual Accounts Payable

$10.73 M
MRVI annual accounts payable is $10.73 million

Debt

Annual Total Debt

$610.97 M
MRVI annual total debt is $610.97 million

Annual Total Debt 1-Year Change

+4.39%
MRVI annual total debt is up +4.39% year-on-year

Annual Long Term Debt

$598.11 M
MRVI annual long term debt is $598.11 million

Annual Short Term Debt

$12.85 M
MRVI annual short term debt is $12.85 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$317.41 M
MRVI annual total expenses is $317.41 million

Annual Operating Expenses

$168.67 M
MRVI annual total operating expenses is $168.67 million

Annual Cost Of Goods Sold

$148.74 M
MRVI annual cost of goods sold is $148.74 million

Annual SGA

$151.39 M
MRVI annual SGA is $151.39 million

Annual D&A

$48.78 M
MRVI annual depreciation & amortization is $48.78 million

Annual Interest Expense

$45.89 M
MRVI annual interest expense is $45.89 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$126.22 M
MRVI annual cash flow from operations is $126.22 million

Annual CFO 1-Year Change

-76.45%
MRVI annual cash flow from operations is down -76.45% year-on-year

Annual CFI

-$122.31 M
MRVI annual cash flow from investing activities is -$122.31 million

Annual CFI 1-Year Change

+54.3%
MRVI annual cash flow from investing activities is up +54.3% year-on-year

Annual CFF

-$61.09 M
MRVI annual cash flow from financing activities is -$61.09 million

Annual CFF 1-Year Change

+67.42%
MRVI annual cash flow from financing activities is up +67.42% year-on-year

Free CashFlow

Annual FCF

$60.67 M
MRVI annual free cash flow is $60.67 million

Annual FCF 1-Year Change

-88.31%
MRVI annual free cash flow is down -88.31% year-on-year

CAPEX

Annual CAPEX

$65.55 M
MRVI annual capital expenditures is $65.55 million

Annual CAPEX 1-Year Change

+283.58%
MRVI annual capital expenditures is up +283.58% year-on-year

Institutional Ownership

Similar stocks

SVRA logo
Savara (SVRA)
TBRG logo
TruBridge (TBRG)
PRTC logo
PureTech Health (PRTC)
DCGO logo
DocGo (DCGO)
OABI logo
OmniAb (OABI)
CLPT logo
ClearPoint Neuro (CLPT)
ARCT logo
Arcturus Therapeutics Holdings (ARCT)
STOK logo
Stoke Therapeutics (STOK)
INNV logo
InnovAge Holding (INNV)

FAQ

  • What is the ticker symbol for Maravai LifeSciences Holdings?
  • Does Maravai LifeSciences Holdings pay dividends?
  • What sector is Maravai LifeSciences Holdings in?
  • What industry is Maravai LifeSciences Holdings in?
  • What country is Maravai LifeSciences Holdings based in?
  • When did Maravai LifeSciences Holdings go public?
  • Is Maravai LifeSciences Holdings in the S&P 500?
  • Is Maravai LifeSciences Holdings in the NASDAQ 100?
  • Is Maravai LifeSciences Holdings in the Dow Jones?
  • When was Maravai LifeSciences Holdings's last earnings report?
  • When does Maravai LifeSciences Holdings report earnings?
  • Should I buy Maravai LifeSciences Holdings stock now?

What is the ticker symbol for Maravai LifeSciences Holdings?

The ticker symbol for Maravai LifeSciences Holdings is NASDAQ:MRVI

Does Maravai LifeSciences Holdings pay dividends?

No, Maravai LifeSciences Holdings does not pay dividends

What sector is Maravai LifeSciences Holdings in?

Maravai LifeSciences Holdings is in the Healthcare sector

What industry is Maravai LifeSciences Holdings in?

Maravai LifeSciences Holdings is in the Biotechnology industry

What country is Maravai LifeSciences Holdings based in?

Maravai LifeSciences Holdings is headquartered in United States

When did Maravai LifeSciences Holdings go public?

Maravai LifeSciences Holdings's initial public offering (IPO) was on November 20, 2020

Is Maravai LifeSciences Holdings in the S&P 500?

No, Maravai LifeSciences Holdings is not included in the S&P 500 index

Is Maravai LifeSciences Holdings in the NASDAQ 100?

No, Maravai LifeSciences Holdings is not included in the NASDAQ 100 index

Is Maravai LifeSciences Holdings in the Dow Jones?

No, Maravai LifeSciences Holdings is not included in the Dow Jones index

When was Maravai LifeSciences Holdings's last earnings report?

Maravai LifeSciences Holdings's most recent earnings report was on Feb 25, 2025

When does Maravai LifeSciences Holdings report earnings?

The date for Maravai LifeSciences Holdings's next earnings report has not been announced yet

Should I buy Maravai LifeSciences Holdings stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions